176 related articles for article (PubMed ID: 17707122)
1. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
[TBL] [Abstract][Full Text] [Related]
2. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.
Klinkenberg M; Thurow N; Gispert S; Ricciardi F; Eich F; Prehn JH; Auburger G; Kögel D
Neuroscience; 2010 Mar; 166(2):422-34. PubMed ID: 20045449
[TBL] [Abstract][Full Text] [Related]
3. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells.
Qu M; Zhou Z; Chen C; Li M; Pei L; Yang J; Wang Y; Li L; Liu C; Zhang G; Yu Z; Wang D
Neurosci Res; 2012 Jan; 72(1):94-102. PubMed ID: 22001761
[TBL] [Abstract][Full Text] [Related]
5. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.
Pridgeon JW; Olzmann JA; Chin LS; Li L
PLoS Biol; 2007 Jul; 5(7):e172. PubMed ID: 17579517
[TBL] [Abstract][Full Text] [Related]
6. L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.
Moriwaki Y; Kim YJ; Ido Y; Misawa H; Kawashima K; Endo S; Takahashi R
Neurosci Res; 2008 May; 61(1):43-8. PubMed ID: 18359116
[TBL] [Abstract][Full Text] [Related]
7. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
Sim CH; Lio DS; Mok SS; Masters CL; Hill AF; Culvenor JG; Cheng HC
Hum Mol Genet; 2006 Nov; 15(21):3251-62. PubMed ID: 17000703
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death.
Huang HM; Ou HC; Xu H; Chen HL; Fowler C; Gibson GE
J Neurosci Res; 2003 Oct; 74(2):309-17. PubMed ID: 14515360
[TBL] [Abstract][Full Text] [Related]
9. Loss of cardiolipin in palmitate-treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis.
Buratta M; Castigli E; Sciaccaluga M; Pellegrino RM; Spinozzi F; Roberti R; Corazzi L
J Neurochem; 2008 May; 105(3):1019-31. PubMed ID: 18182042
[TBL] [Abstract][Full Text] [Related]
10. Cd(2+)-induced cytochrome c release in apoptotic proximal tubule cells: role of mitochondrial permeability transition pore and Ca(2+) uniporter.
Lee WK; Bork U; Gholamrezaei F; Thévenod F
Am J Physiol Renal Physiol; 2005 Jan; 288(1):F27-39. PubMed ID: 15339793
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects.
Amo T; Sato S; Saiki S; Wolf AM; Toyomizu M; Gautier CA; Shen J; Ohta S; Hattori N
Neurobiol Dis; 2011 Jan; 41(1):111-8. PubMed ID: 20817094
[TBL] [Abstract][Full Text] [Related]
12. Silencing of PINK1 induces mitophagy via mitochondrial permeability transition in dopaminergic MN9D cells.
Cui T; Fan C; Gu L; Gao H; Liu Q; Zhang T; Qi Z; Zhao C; Zhao H; Cai Q; Yang H
Brain Res; 2011 Jun; 1394():1-13. PubMed ID: 21262209
[TBL] [Abstract][Full Text] [Related]
13. Anti-Bcl-2 family members, zfBcl-x(L) and zfMcl-1a, prevent cytochrome c release from cells undergoing betanodavirus-induced secondary necrotic cell death.
Chen SP; Wu JL; Su YC; Hong JR
Apoptosis; 2007 Jun; 12(6):1043-60. PubMed ID: 17245642
[TBL] [Abstract][Full Text] [Related]
14. Novel PINK1 mutations in early-onset parkinsonism.
Hatano Y; Li Y; Sato K; Asakawa S; Yamamura Y; Tomiyama H; Yoshino H; Asahina M; Kobayashi S; Hassin-Baer S; Lu CS; Ng AR; Rosales RL; Shimizu N; Toda T; Mizuno Y; Hattori N
Ann Neurol; 2004 Sep; 56(3):424-7. PubMed ID: 15349870
[TBL] [Abstract][Full Text] [Related]
15. Lycopene protects against trimethyltin-induced neurotoxicity in primary cultured rat hippocampal neurons by inhibiting the mitochondrial apoptotic pathway.
Qu M; Zhou Z; Chen C; Li M; Pei L; Chu F; Yang J; Wang Y; Li L; Liu C; Zhang L; Zhang G; Yu Z; Wang D
Neurochem Int; 2011 Dec; 59(8):1095-103. PubMed ID: 22032970
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A prevents vascular hyperpermeability after hemorrhagic shock by inhibiting apoptotic signaling.
Tharakan B; Holder-Haynes JG; Hunter FA; Smythe WR; Childs EW
J Trauma; 2009 Apr; 66(4):1033-9. PubMed ID: 19359911
[TBL] [Abstract][Full Text] [Related]
17. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
18. PPAR-γ activation attenuates deltamethrin-induced apoptosis by regulating cytosolic PINK1 and inhibiting mitochondrial dysfunction.
Ko J; Park JH; Park YS; Koh HC
Toxicol Lett; 2016 Oct; 260():8-17. PubMed ID: 27553674
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
